Lewisville, Texas-based Bio-American's ANDA suitability petition for a 150 mg phenylpropanolamine patch for weight loss denied by FDA Oct. 7. Noting that phenylpropanolamine is not generally recognized as safe and effective for weight loss, the agency explained that ANDA petition route cannot be used unless the final monograph on OTC weight loss products, which has not yet been issued, recognizes the 150 mg strength of the ingredient. Weight loss panel recommended that only a 75 mg strength be listed as safe and effective for weight loss.
You may also be interested in...
Pink Sheet reporters and editor discuss President-Elect Joe Biden’s decision to name the CDER director as acting FDA commissioner and other staffing changes, as well as changes to industry trade groups’ political donations.
Delfi Diagnostics will use the new funds to expand its team of cancer researchers and machine-learning experts to validate its novel approach for early cancer detection through multiple prospective clinical trials.
US Ninth Circuit affirms a district court’s summary judgment in favor of Target and manufacturer of Up & Up brand biotin supplement it sells. Indian manufacturer targeted in putative class-action in New York prompted FDA’s 2016 creation of import alert category for Ayurvedic supplements.